piribedil has been researched along with Gelineau Syndrome in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three patients with Parkinson's disease had so-called sleep attacks at the wheel while taking bromocryptine, lisuride pergolide, or piribedil." | 1.31 | Sleep attacks and Parkinson's disease treatment. ( Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, JJ | 1 |
| Galitzky, M | 1 |
| Montastruc, JL | 1 |
| Rascol, O | 1 |
1 other study available for piribedil and Gelineau Syndrome
| Article | Year |
|---|---|
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Li | 2000 |